Loading
IARC estimates 8,124 new cancer cases and 5,218 cancer deaths in South Sudan in 2024; the commonest new cancers are breast, cervix uteri and prostate. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for South Sudan's incidence estimate is 5: rates based on incidence estimates or registry data from neighbouring countries. Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 1,760 | 39.0 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 890 | 21.6 | Cervical cancer |
| Prostate | 629 | 27.4 | Prostate cancer |
| Colorectum | 564 | 7.7 | Colorectal cancer |
| Liver and intrahepatic bile ducts | 393 | 5.5 | Hepatocellular carcinoma |
| Leukaemia | 338 | 3.7 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Non-Hodgkin lymphoma | 272 | 3.3 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Oesophagus | 263 | 4.0 | Oesophageal cancer |
| Stomach | 213 | 3.1 | Gastric & gastro-oesophageal junction cancer |
| Ovary | 197 | 4.6 | Ovarian cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Breast | 840 | 19.2 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 554 | 13.6 | Cervical cancer |
| Prostate | 401 | 17.1 | Prostate cancer |
| Liver and intrahepatic bile ducts | 361 | 5.1 | Hepatocellular carcinoma |
| Colorectum | 323 | 4.6 | Colorectal cancer |
| Oesophagus | 239 | 3.7 | Oesophageal cancer |
| Leukaemia | 230 | 2.6 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Stomach | 171 | 2.6 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 171 | 2.6 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Non-Hodgkin lymphoma | 153 | 2.0 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
No trial record in OnCo lists a site in South Sudan. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in South Sudan.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. South Sudan is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
South Sudan is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.